DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
PO-GePV-T-22 | Comparison of Eye Plaque Dosimetry Between MIM Symphony, Eclipse, and CMS Xio Treatment Planning Systems R Varadhan1*, M Bedoya2 , C Ferreira3 , M Fox4 , C Johnson5 , (1) Minneapolis Radiation Oncology, Fridley, MN, (2) University of Minnesota, Minneapolis, MN, (3) University of Minnesota, Minneapolis, MN, (4) Minneapolis Radiation Oncology, Minneapolis, MN, (5) Minneapolis Radiation Oncology, Edina, |
PO-GePV-T-23 | Treatment of a Vasoproliferative Retinal Tumor (VPT) Using I-125 Eye Plaque Radiotherapy S Howard1*, V Massey2 , S Howard3 , (1) University of Kansas Hospital, Overland Park, KS, (2) University of Kansas Medical Center, Overland Park, KS |
PO-GePV-T-29 | Application of Hybrid Source in Slotted Plaque Brachytherapy for the Treatment of Uveal Melanoma and Dosimetric Comparison of Plans with I-125 and Pd-103 Sources S Awan1*, A Meigooni2 , S Howard3 , A Tejwani4 , R Badkul5 , H Saleh6 , (1) University of Kansas Hospital/Stormont Vail Hospital Topeka, KS, ,KS, (2) Comprehensive Cancer Center of Nevada, Las Vegas, NV, (3) University of Kansas Hospital, Overland Park, KS, (4) KU Medical Center/ Stormont Vail Hospital Topeka, KS, Kansas City, KS, (5) Univ Kansas Medical Center, Kansas City, KS, (6) The University of Kansas Cancer Centers, Kansas City, KS |
SU-E-301-3 | Dosimetric Impact of Silastic Insert Thickness in COMS Eye Plaque for I-125 Brachytherapy C Oare*, D Sterling , K Dusenbery , D Koozekanani , C Ferreira , University of Minnesota, Minneapolis, MN |
TU-F115-GePD-F4-4 | Report of Radiobiological Doses for the Treatment of Ocular Malignancies with Brachytherapy Z Richards*, B Firestone , C Henson , S Ahmad , T Herman , T De La Fuente Herman , University of Oklahoma Health Sciences Center, Oklahoma City, OK |